is an independent company that provides health improvement management services to CareFirst members.
In a randomized trial, Gelesis100 produced modest placebo-adjusted weight loss
This is why every medical professional, every pharmacy, and every manufacturer gives the same advice about expired semaglutide
Add in the lack of regulation, potential purity issues, and unknown long-term safety profile, and you have a compound that demands informed decision-making
That allowance ended with the shortage: FDA enforcement discretion for compounded semaglutide closed on April 22 and May 22, 2025, following the tirzepatide dates of February 18 and March 19, 2025
We are also indebted to Andrea C